Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry.
Cordero A, Fernández Olmo MR, Cortez Quiroga GA, Romero-Menor C, Fácila L, Seijas-Amigo J, Rondán Murillo J, Sandin M, Rodríguez-Mañero M, Bello Mora MC, Valle A, Fornovi A, Freixa Pamias R, Bañeras J, Blanch García P, Clemente Lorenzo MM, Sánchez-Álvarez S, López-Rodríguez L, González-Juanatey JR. Cordero A, et al. Eur J Clin Invest. 2022 Dec;52(12):e13863. doi: 10.1111/eci.13863. Epub 2022 Sep 5. Eur J Clin Invest. 2022. PMID: 36039486
Anticoagulation prescription in atrial fibrillation.
Bertomeu-González V, Cordero A, Mazón P, Moreno-Arribas J, Fácila L, Nuñez J, Rodríguez-Mañero M, Cosín-Sales J, González-Juanatey JR, Quiles J, Bertomeu-Martínez V; investigators of the CARDIOTENS2 study. Bertomeu-González V, et al. Expert Opin Pharmacother. 2011 Jul;12(10):1473-9. doi: 10.1517/14656566.2011.584063. Epub 2011 Jun 2. Expert Opin Pharmacother. 2011. PMID: 21635195
Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists.
Abumuaileq RR, Abu-Assi E, Raposeiras-Roubin S, López-López A, Redondo-Diéguez A, Álvarez-Iglesias D, Rodríguez-Mañero M, Peña-Gil C, González-Juanatey JR. Abumuaileq RR, et al. Europace. 2015 May;17(5):711-7. doi: 10.1093/europace/euu353. Epub 2015 Feb 5. Europace. 2015. PMID: 25662984
Is safe to discontinue anticoagulation after successful ablation of atrial flutter?
Raposeiras-Roubín S, García-Seara J, Cabanas-Grandío P, Abu-Assi E, Rodríguez-Mañero M, Fernández-López JA, Martínez-Sande L, González-Juanatey JR. Raposeiras-Roubín S, et al. Int J Cardiol. 2015 Dec 15;201:631-2. doi: 10.1016/j.ijcard.2014.12.154. Epub 2015 Jan 14. Int J Cardiol. 2015. PMID: 26343024 No abstract available.
Prognostic Effect of Body Mass Index in Patients With an Implantable Cardioverter-defibrillator for Primary Prevention of Sudden Death.
González-Cambeiro MC, Rodríguez-Mañero M, Abellas-Sequeiros A, Moreno-Arribas J, Filgueira-Rama D, González-Juanatey JR. González-Cambeiro MC, et al. Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):990-992. doi: 10.1016/j.rec.2016.04.055. Epub 2016 Jul 29. Rev Esp Cardiol (Engl Ed). 2016. PMID: 27480908 English, Spanish. No abstract available.
211 results